Home Compare AMP.MI vs CAH
Stock Comparison · Industry comparison · Medical Distribution

Amplifon S.p.A. vs Cardinal Health: Which Stock Looks Stronger in 2026?

Cardinal Health holds the cleaner structural position, with the lead spread across growth and profitability. Amplifon S.p.A does not offset that deficit through any equally strong structural edge elsewhere. On the market side, Cardinal Health is in better shape — its trend is intact while Amplifon S.p.A's trend has broken down. That puts structure and market broadly in agreement — Cardinal Health's lead looks more confirmed than conflicted.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

This is not just a one-metric split: both growth and profitability materially support the lead. Cardinal Health, Inc. leads by 41 points on the overall comparison score.

INDUSTRY COMPARISON

Both operate in: Medical Distribution

This comparison is based on industry proximity, not on functional trajectory similarity. AMP.MI and CAH share the same industry classification.

For a similarity-based comparison, see how Amplifon S.p.A and Cardinal Health each position within their functional peer groups in AssetNext.

Peer-Relative Score
AMP.MI
Amplifon S.p.A.
24
Peer-Score
Signal qualityMedium
vs
CAH
Cardinal Health, Inc.
65
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: AMP.MI vs CAH Profitability 14 68 Stability 9 57 Valuation 57 60 Growth 5 75 AMP.MI CAH
Gap Ranking
#1 Growth +70
#2 Profitability +54
#3 Stability +48
#4 Valuation +3
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for AMP.MI and CAH Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer AMP.MICAH Relative valuation Structural strength

Neither company combines the stronger profile with the cheaper valuation.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
Cardinal Health, Inc. ranks near the top of the group on growth; Amplifon S.p.A. sits in the weaker half.
Profitability
On profitability, the gap still runs the same way: Cardinal Health, Inc. sits near the top of the group, while Amplifon S.p.A. remains in the weaker half.
Growth — Dominant Gap
AMP.MI
5
CAH
75
Gap+70in favour of CAH

One company is still expanding while the other is contracting, which creates a very wide growth split.

What else supports the lead

Capital efficiency adds support, with a 44-point ROIC advantage.

What this means for the comparison

The lead is built on both growth and profitability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the AMP.MI vs CAH comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar growth-and-profitability comparisons

Explore how AMP.MI and CAH each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.